P. Cleary

P. Cleary, K. Sie, Henry C. Ou, 2010, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Myocardial Structure, Function, and Scar in Patients With Type 1 Diabetes Mellitus

D. Bluemke, J. Lima, E. Soliman, 2011, Circulation.

Insulin secretion measured by stimulated C‐peptide in long‐established Type 1 diabetes in the Diabetes Control and Complications Trial (DCCT)/ Epidemiology of Diabetes Interventions and Complications (EDIC) cohort: a pilot study

J. Lachin, P. Cleary, M. Steffes, 2014, Diabetic medicine : a journal of the British Diabetic Association.

Ovarian reserve in women with Type 1 diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study

R. Dunn, M. Wellons, P. Cleary, 2016, Diabetic medicine : a journal of the British Diabetic Association.

Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus.

Matthew D. Davis, S. Genuth, D. Nathan, 2002, JAMA.

Comparison of urinary albumin-creatinine ratio and albumin excretion rate in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study.

I. D. de Boer, J. Lachin, P. Cleary, 2010, Clinical journal of the American Society of Nephrology : CJASN.

Significance of Epicardial and Intrathoracic Adipose Tissue Volume among Type 1 Diabetes Patients in the DCCT/EDIC: A Pilot Study

M. Budoff, J. Lachin, P. Cleary, 2016, PloS one.

Quality control functions of the Visual Field Reading Center (VFRC) for the Optic Neuritis Treatment Trial (ONTT).

C A Johnson, J L Keltner, R W Beck, 1993, Controlled clinical trials.

Side effects of glucocorticoid treatment. Experience of the Optic Neuritis Treatment Trial.

R. Beck, G. Chrousos, P. Cleary, 1993, JAMA.

Response to Comment on Lopes-Virella et al. Baseline Markers of Inflammation Are Associated With Progression to Macroalbuminuria in Type 1 Diabetic Subjects. Diabetes Care 2013;36:2317–2323

K. Hunt, P. Cleary, N. Baker, 2014, Diabetes Care.

The Effect of Excess Weight Gain with Intensive Diabetes Treatment on Cardiovascular Disease Risk Factors and Atherosclerosis in Type 1 Diabetes: Results from the Diabetes Control and Complications Trial / Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) Study

J. Hokanson, B. Zinman, D. Nathan, 2012 .

Erratum: Baseline analysis of renal function in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group (Kidney International 43 (1993) 668-674)

D. Nathan, P. Cleary, M. Steffes, 1993 .

Effect of Intensive Glycemic Control and Diabetes Complications on Lower Urinary Tract Symptoms in Men With Type 1 Diabetes

S. K. Van Den Eeden, J. Kusek, P. Cleary, 2009, Diabetes Care.

Intensive Diabetes Therapy Reduces Ocular Surgeries in Patients with Type 1 Diabetes: twenty-eight year followup of the Diabetes Control and Complications Trial / Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC)

L. Aiello, R. Klein, R. Danis, 2013 .

Severe hypoglycaemia in Diabetes Control and Complications Trial

S. Genuth, D. Nathan, J. Lachin, 1994, The Lancet.

Response to Moses

S. Genuth, D. Nathan, J. Lachin, 1996, Diabetes Care.

Mortality in Type 1 Diabetes in the DCCT/EDIC Versus the General Population

J. Lachin, P. Cleary, I. Bebu, 2016, Diabetes Care.

Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality.

B. Zinman, D. Nathan, J. Lachin, 2015, JAMA.

Aortic Distensibility in Type 1 Diabetes

D. Bluemke, J. Lima, A. Redheuil, 2013, Diabetes Care.

Erratum: Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetes (Diabetes Case (1999) 22 (1165-1170))

J. Hokanson, P. Cleary, M. Steffes, 1999 .

The Effect of Intensive Diabetes Treatment on Resting Heart Rate in Type 1 Diabetes

A. Paterson, J. Lachin, P. Cleary, 2007, Diabetes Care.

Progression of Carotid Artery Intima-Media Thickness During 12 Years in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study

J. Polak, D. O'leary, D. Nathan, 2011, Diabetes.

Reproducibility of a comprehensive diet history in the Diabetes Control and Complications Trial. The DCCT Research Group.

P. Cleary, I. Buzzard, M. Cox, 1994, Journal of the American Dietetic Association.

Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study.

B. Zinman, J. Lachin, P. Cleary, 2014, The lancet. Diabetes & endocrinology.

Prevalence of low testosterone and predisposing risk factors in men with type 1 diabetes mellitus: findings from the DCCT/EDIC.

R. Dunn, W. Herman, P. Cleary, 2014, The Journal of clinical endocrinology and metabolism.

Progestins and oral contraceptive-induced lipoprotein changes: a prospective study.

P. Cleary, J. Larosa, V. Miller, 1986, Contraception.

Contrast sensitivity and other vision tests in the optic neuritis treatment trial.

J D Trobe, R W Beck, P A Cleary, 1996, American journal of ophthalmology.

Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.

W. Tamborlane, S. Genuth, D. Nathan, 1999, Diabetes care.

The natural history of cholelithiasis: the National Cooperative Gallstone Study.

J M Lachin, P A Cleary, M P Tyor, 1984, Annals of internal medicine.

Evaluating the Role of Epigenetic Histone Modifications in the Metabolic Memory of Type 1 Diabetes

A. Paterson, A. Riggs, D. Harlan, 2014, Diabetes.

Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Contro

S. Genuth, V. Monnier, J. Lachin, 1999, Diabetes.

T‐cell abnormalities after mediastinal irradiation for lung cancer. The in vitro influence of synthetic thymosin alpha‐1

P. Cleary, A. Goldstein, O. Alabaster, 1985, Cancer.

Renal outcomes in patients with type 1 diabetes and macroalbuminuria.

B. Zinman, I. D. de Boer, J. Lachin, 2014, Journal of the American Society of Nephrology : JASN.

Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study.

B. Kestenbaum, I. D. de Boer, N. Weiss, 2007, Journal of the American Society of Nephrology : JASN.

Glycaemic control and risk of incident urinary incontinence in women with Type 1 diabetes: results from the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study

W. Herman, P. Cleary, A. Jacobson, 2016, Diabetic medicine : a journal of the British Diabetic Association.

The association between skin collagen glucosepane and past progression of microvascular and neuropathic complications in type 1 diabetes.

S. Genuth, V. Monnier, J. Lachin, 2013, Journal of diabetes and its complications.

Sexual Dysfunction in Women With Type 1 Diabetes

P. Cleary, R. Rosen, Markus Wiegel, 2009, Diabetes Care.

A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.

J L Keltner, D I Kaufman, E G Buckley, 1992, The New England journal of medicine.

Visual Symptoms After Optic Neuritis: Results from the Optic Neuritis Treatment Trial

R. Beck, L. Bourque, P. Cleary, 1997, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

Brain magnetic resonance imaging in acute optic neuritis. Experience of the Optic Neuritis Study Group.

R. Beck, D. Kaufman, P. Cleary, 1993, Archives of neurology.

Relationship of family history of type 2 diabetes, hypoglycemia, and autoantibodies to weight gain and lipids with intensive and conventional therapy in the Diabetes Control and Complications Trial.

J. Hokanson, I. Hirsch, P. Cleary, 2003, Diabetes.

Design, methods, and conduct of the Optic Neuritis Treatment Trial.

R. Beck, P. Cleary, J. Backlund, 1993, Controlled clinical trials.

Caffeine Consumption Contributes to Skin Intrinsic Fluorescence in Type 1 Diabetes

A. Paterson, D. Grant, P. Cleary, 2015, Diabetes technology & therapeutics.

GWAS identifies an NAT2 acetylator status tag single nucleotide polymorphism to be a major locus for skin fluorescence

A. Paterson, R. Klein, H. Snieder, 2014, Diabetologia.

Clinical and technical factors associated with skin intrinsic fluorescence in subjects with type 1 diabetes from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.

C. Cowie, P. Cleary, T. Lyons, 2013, Diabetes technology & therapeutics.

Long-term effect of diabetes and its treatment on cognitive function.

P. Cleary, C. Ryan, A. Jacobson, 2007, The New England journal of medicine.

Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort.

B. Zinman, I. D. de Boer, L. Hubbard, 2011, Archives of internal medicine.

Association of Cardiovascular Risk Factors and Myocardial Fibrosis With Early Cardiac Dysfunction in Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study

D. Bluemke, J. Lima, E. Turkbey, 2016, Diabetes Care.

Association of diet with glycated hemoglobin during intensive treatment of type 1 diabetes in the Diabetes Control and Complications Trial.

F. Hu, J. Wylie-Rosett, D. Nathan, 2009, The American journal of clinical nutrition.

Effect of Prior Intensive Insulin Treatment During the Diabetes Control and Complications Trial (DCCT) on Peripheral Neuropathy in Type 1 Diabetes During the Epidemiology of Diabetes Interventions and Complications (EDIC) Study

J. Albers, W. Herman, J. Lachin, 2010, Diabetes Care.

Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications

J. Albers, W. Herman, P. Cleary, 2012, Diabetic medicine : a journal of the British Diabetic Association.

Effects of Prior Intensive Insulin Therapy on Cardiac Autonomic Nervous System Function in Type 1 Diabetes Mellitus: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC)

J. Albers, W. Herman, J. Lachin, 2009, Circulation.

Baseline analysis of renal function in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group [corrected].

P A Cleary, D. Nathan, P. Cleary, 1993, Kidney international.

Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes.

Mark E Molitch, John M Lachin, Wanjie Sun, 2011, The New England journal of medicine.

Biomedical risk factors for decreased cognitive functioning in type 1 diabetes: an 18 year follow-up of the Diabetes Control and Complications Trial (DCCT) cohort

P. Cleary, C. Ryan, A. Jacobson, 2011, Diabetologia.

Longitudinal Association Between Endothelial Dysfunction, Inflammation, and Clotting Biomarkers With Subclinical Atherosclerosis in Type 1 Diabetes: An Evaluation of the DCCT/EDIC Cohort

K. Hunt, P. Cleary, N. Baker, 2015, Diabetes Care.

Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial.

David M Nathan, Larry D Hubbard, Ronald P Danis, 2008, Archives of ophthalmology.

Hemoglobin A1c measurements over nearly two decades: sustaining comparable values throughout the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications study.

R. Little, H. Wiedmeyer, P. Cleary, 2005, Clinical chemistry.

Development and Progression of Renal Insufficiency With and Without Albuminuria in Adults With Type 1 Diabetes in the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications Study

B. Zinman, I. D. de Boer, J. Lachin, 2010, Diabetes Care.

The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group.

R. Beck, D. Paty, C. Brown, 1993, The New England journal of medicine.

Skin Advanced Glycation End Products Glucosepane and Methylglyoxal Hydroimidazolone Are Independently Associated With Long-term Microvascular Complication Progression of Type 1 Diabetes

S. Genuth, V. Monnier, J. Lachin, 2014, Diabetes.

DCCT and EDIC Studies in Type 1 Diabetes: Lessons for Diabetic Neuropathy Regarding Metabolic Memory and Natural History

J. Albers, W. Herman, J. Lachin, 2010, Current diabetes reports.

Effect of Prior Intensive Therapy in Type 1 Diabetes on 10-Year Progression of Retinopathy in the DCCT/EDIC: Comparison of Adults and Adolescents

Neil H. White, Matthew D. Davis, Ronald P. Danis, 2010, Diabetes.

Testosterone and cardiac mass and function in men with type 1 diabetes in the Epidemiology of Diabetes Interventions and Complications Study (EDIC)

P. Cleary, M. Steffes, T. Orchard, 2016, Clinical endocrinology.

Sexual dysfunction and symptom impact in men with long-standing type 1 diabetes in the DCCT/EDIC cohort.

D. Penson, P. Cleary, H. Wessells, 2009, The journal of sexual medicine.

Effect of intensive glycemic therapy on erectile function in men with type 1 diabetes.

D. Penson, J. Lachin, P. Cleary, 2011, The Journal of urology.

The course of visual recovery after optic neuritis. Experience of the Optic Neuritis Treatment Trial.

R. Beck, P. Cleary, J. C. Backlund, 1994, Ophthalmology.

Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion.

James Albers, Eva L Feldman, J. Albers, 2006, Diabetes care.

Insulin therapy, hyperglycemia, and hypertension in type 1 diabetes mellitus.

B. Kestenbaum, I. D. de Boer, N. Weiss, 2008, Archives of internal medicine.

Decreased plasma levels of select very long chain ceramide species are associated with the development of nephropathy in type 1 diabetes.

K. Hunt, P. Cleary, N. Baker, 2014, Metabolism: clinical and experimental.

Lymphoblastoid Cell Lines as a Tool to Study Inter-Individual Differences in the Response to Glucose

A. Paterson, R. S. Huang, Dingcai Cao, 2016, PloS one.

Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study.

John M. Lachin, Michael W. Steffes, Mark E. Molitch, 2003, JAMA.

A screening algorithm to identify clinically significant changes in neuropsychological functions in the Diabetes Control and Complications Trial. DCCT Research Group.

I. Grant, R. Heaton, K. Adams, 1994, Journal of clinical and experimental neuropsychology.

Longitudinal changes in estimated and measured GFR in type 1 diabetes.

B. Zinman, I. D. de Boer, J. Lachin, 2014, Journal of the American Society of Nephrology : JASN.

Impact of Excessive Weight Gain on Cardiovascular Outcomes in Type 1 Diabetes: Results From the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study

B. Zinman, P. Cleary, W. Sivitz, 2017, Diabetes Care.

Haptoglobin 2-2 genotype and the risk of coronary artery disease in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC).

J. Lachin, P. Cleary, T. Orchard, 2016, Journal of diabetes and its complications.

New Locus for Skin Intrinsic Fluorescence in Type 1 Diabetes Also Associated With Blood and Skin Glycated Proteins

Angelo J. Canty, A. Paterson, S. Bull, 2016, Diabetes.

Progression of Electrocardiographic Abnormalities in Type 1 Diabetes During 16 Years of Follow‐up: The Epidemiology of Diabetes Interventions and Complications (EDIC) Study

E. Soliman, J. Lachin, P. Cleary, 2016, Journal of the American Heart Association.

Delayed Gastric Emptying Is Associated With Early and Long-term Hyperglycemia in Type 1 Diabetes Mellitus.

A. Zinsmeister, W. Herman, J. Murray, 2015, Gastroenterology.

Cardiovascular autonomic neuropathy, erectile dysfunction and lower urinary tract symptoms in men with type 1 diabetes: findings from the DCCT/EDIC.

R. Dunn, P. Cleary, R. Pop-Busui, 2015, The Journal of urology.

Musculoskeletal Complications in Type 1 Diabetes

D. Nathan, P. Cleary, E. Golden, 2014, Diabetes Care.

Effects of Prior Intensive Versus Conventional Therapy and History of Glycemia on Cardiac Function in Type 1 Diabetes in the DCCT/EDIC

D. Bluemke, J. Lima, E. Turkbey, 2013, Diabetes.

The Long-Term Effects of Type 1 Diabetes Treatment and Complications on Health-Related Quality of Life

P. Cleary, A. Jacobson, R. Gubitosi-Klug, 2013, Diabetes Care.

Baseline Markers of Inflammation Are Associated With Progression to Macroalbuminuria in Type 1 Diabetic Subjects

K. Hunt, P. Cleary, N. Baker, 2013, Diabetes Care.

The Association of Skin Intrinsic Fluorescence With Type 1 Diabetes Complications in the DCCT/EDIC Study

C. Cowie, P. Cleary, T. Lyons, 2013, Diabetes Care.

An enzyme linked immunosorbent assay (ELISA) for the determination of the human haptoglobin phenotype

A. Paterson, M. Rewers, J. Snell-Bergeon, 2013, Clinical chemistry and laboratory medicine.

The Long-Term Effects of Type 1 Diabetes Treatment andComplications on Health-Related Quality of Life A 23-year follow-up of the Diabetes Control and Complications / Epidemiology of Diabetes Interventions and Complications cohort

P. Cleary, A. Jacobson, R. Gubitosi-Klug, 2013 .

Participant characteristics and study features associated with high retention rates in a longitudinal investigation of type 1 diabetes mellitus

P. Cleary, J. Kramer, M. E. Lackaye, 2012, Clinical trials.

Urinary incontinence among women with type 1 diabetes--how common is it?

E. Vittinghoff, J. Kusek, P. Cleary, 2009, The Journal of urology.

Impact of Diabetes and Its Treatment on Cognitive Function Among Adolescents Who Participated in the Diabetes Control and Complications Trial

N. White, P. Cleary, C. Ryan, 2008, Diabetes Care.

Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial.

P A Cleary, S M Marcovina, J. Hokanson, 1998, JAMA.

Testosterone Concentrations and Cardiovascular Autonomic Neuropathy in Men with Type 1 Diabetes in the Epidemiology of Diabetes Interventions and Complications Study (EDIC).

P. Cleary, T. Orchard, I. Bebu, 2015, The journal of sexual medicine.

Association between cardiovascular autonomic neuropathy and left ventricular dysfunction: DCCT/EDIC study (Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications).

D. Bluemke, J. Lima, W. Herman, 2013, Journal of the American College of Cardiology.

The Effect of Intensive Glycemic Treatment on Coronary Artery Calcification in Type 1 Diabetic Participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study

David M Nathan, Robert Detrano, John M Lachin, 2006, Diabetes.

Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT).

P A Cleary, M. Goldbaum, S. Schwartz, 2001, The Journal of pediatrics.

Validity of self-report in type 1 diabetic subjects for laser treatment of retinopathy.

R. Klein, L. Hubbard, R. Danis, 2013, Ophthalmology.

Albuminuria Changes and Cardiovascular and Renal Outcomes in Type 1 Diabetes: The DCCT/EDIC Study.

A. Paterson, B. Zinman, I. D. de Boer, 2016, Clinical journal of the American Society of Nephrology : CJASN.

Circulating vitamin D metabolites and kidney disease in type 1 diabetes.

B. Zinman, I. D. de Boer, A. Hoofnagle, 2012, The Journal of clinical endocrinology and metabolism.

Glycemic Control and Urinary Tract Infections in Women with Type 1 Diabetes: Results from the DCCT/EDIC.

R. Dunn, W. Herman, P. Cleary, 2016, The Journal of urology.

Urinary tract infections in women with type 1 diabetes mellitus: survey of female participants in the epidemiology of diabetes interventions and complications study cohort.

P. Cleary, A. Stapleton, K. Chan, 2009, The Journal of urology.

Risk factors for urinary incontinence among women with type 1 diabetes: findings from the epidemiology of diabetes interventions and complications study.

E. Vittinghoff, J. Kusek, P. Cleary, 2009, Urology.

Intensive diabetes therapy and ocular surgery in type 1 diabetes.

L. Aiello, R. Klein, S. Gangaputra, 2015, The New England journal of medicine.

Oxidized LDL and AGE-LDL in circulating immune complexes strongly predict progression of carotid artery IMT in type 1 diabetes.

K. Hunt, A. Jenkins, P. Cleary, 2013, Atherosclerosis.

Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group.

Siebert, M. Schluchter, A. Levey, 1993, Journal of the American Society of Nephrology : JASN.

National Cooperative Gallstone Study: the effect of chenodeoxycholic acid on lipoproteins and apolipoproteins.

S. Grundy, J. Lachin, P. Cleary, 1982, Gastroenterology.

Circulating Vitamin D Metabolites and Subclinical Atherosclerosis in Type 1 Diabetes

B. Zinman, I. D. de Boer, A. Hoofnagle, 2013, Diabetes Care.

Evolution of the study coordinator role: The 28-year experience in Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC)

S. Genuth, P. Cleary, E. Golden, 2012, Clinical trials.

Skin collagen fluorophore LW-1 versus skin fluorescence as markers for the long-term progression of subclinical macrovascular disease in type 1 diabetes

S. Genuth, V. Monnier, J. Lachin, 2016, Cardiovascular Diabetology.

Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes

S. Genuth, V. Monnier, J. Lachin, 2015, Cardiovascular Diabetology.

Vibration Perception Threshold as a Measure of Distal Symmetrical Peripheral Neuropathy in Type 1 Diabetes

J. Albers, W. Herman, P. Cleary, 2010, Diabetes Care.

Effects of Prior Intensive Insulin Therapy and Risk Factors on Patient-Reported Visual Function Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort.

L. Aiello, R. Klein, W. Tamborlane, 2016, JAMA ophthalmology.

The predictive role of markers of Inflammation and endothelial dysfunction on the course of diabetic retinopathy in type 1 diabetes.

K. Hunt, J. Lachin, P. Cleary, 2015, Journal of diabetes and its complications.

DNA methylation age calculators reveal association with diabetic neuropathy in type 1 diabetes

Angelo J. Canty, J. Keith Jones, A. Paterson, 2020, Clinical Epigenetics.

Disparity in management of diabetes and coronary heart disease risk factors by sex in DCCT/EDIC

P. Cleary, M. Larkin, M. Bayless, 2010, Diabetic medicine : a journal of the British Diabetic Association.

Haptoglobin Genotype and the Rate of Renal Function Decline in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study

A. Paterson, P. Raskin, S. Genuth, 2013, Diabetes.

Self-Reported Autoimmune Disease by Sex in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study

R. Dunn, C. Cowie, D. Nathan, 2014, Diabetes Care.

The associations of apolipoprotein E and angiotensin‐converting enzyme polymorphisms and cognitive function in Type 1 diabetes based on an 18‐year follow‐up of the DCCT cohort

A. Paterson, P. Cleary, C. Ryan, 2010, Diabetic medicine : a journal of the British Diabetic Association.

Color photography vs fluorescein angiography in the detection of diabetic retinopathy in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group.

Larry D. Hubbard, Matthew D. Davis, L. Hubbard, 1987, Archives of ophthalmology.

Oxidative Stress and Cardiovascular Risk in Type 1 Diabetes Mellitus: Insights From the DCCT/EDIC Study

J. Keith Jones, A. Paterson, S. Mudaliar, 2018, Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease.

Relationship of Urologic Complications With Health-Related Quality of Life and Perceived Value of Health in Men and Women With Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Interventions and Complications (DCCT/EDIC) Cohort

R. Dunn, P. Cleary, A. Jacobson, 2015, Diabetes Care.

Poor glycemic control is associated with reduced prostate specific antigen concentrations in men with type 1 diabetes.

R. Dunn, W. Herman, P. Cleary, 2012, The Journal of urology.

Quality Control Measures over 30 Years in a Multicenter Clinical Study: Results from the Diabetes Control and Complications Trial / Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study

E. Soliman, R. Danis, P. Cleary, 2015, PloS one.

The Course of Visual Recovery after Optic Neuritis: Experience of the Optic Neuritis Treatment Trial.

R. Beck, P. Cleary, J. C. Backlund, 2020, Ophthalmology.

Recovery from severe visual loss in optic neuritis.

R. Beck, P. Cleary, 1993, Archives of ophthalmology.

The use of bioelectrical impedance analysis (BIA) to estimate body composition in the Diabetes Control and Complications Trial (DCCT).

Lawrence A Leiter, B. Zinman, P. Cleary, 1994, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

The Pelli-Robson letter chart: normative data for young adults

R. Beck, P. Cleary, L. Diehl, 1993 .

Effects of a prescribed supervised exercise program on mortality and cardiovascular morbidity in patients after a myocardial infarction: The National Exercise and Heart Disease Project∗☆

C. A. Gilbert, J. W. Daly, P. Gorman, 1981 .